Categories 2021 Article Clinical trials Phase II Studies Toxicity Accelerator-based BNCT for patients with recurrent glioblastoma: a multicenter phase II study Post author By ISNCT Post date May 1, 2021 Neuro-Oncology Advances, 2021 Tags Hiroki Tanaka, Hiromi Goto, Katsumi Hirose, Minoru Suzuki, Neuro-Oncology Advances, Shin-ichi Miyatake, Shinji Kawabata, Takahiro Kato, Yoshitaka Narita
ISNCTISNCT